AOD 9604 helps burn fat, but inadequate protein will still result in muscle loss
5-Amino-1MQ selectively blocks NNMT, preventing methyl-group transfer and, in research models, helping preserve SAM and NAD availability
Observed effects in human trials Reported adverse events across the IV and oral trials included headache, fatigue, dizziness, nasopharyngitis, diarrhea, flatulence, increased appetite, nausea, and back pain
For those managing a diagnosed deficiency, ongoing treatments may be recommended on a consistent schedule
GIPR:GCGR co-agonism restores normal weight in obese rodents
Unlike other companies that may increase fees as your dose increases, we offer consistent pricing for every dose and medication